Simonetta Geninatti Crich

Associate professor

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Medical Imaging Medical Imaging professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Simonetta Geninatti Crich is an Associate Professor at the University of Torino, Italy. Her research focuses on innovative therapies for cancer treatment, including boron neutron capture therapy (BNCT), MRI-guided therapies, and the development of targeted delivery systems for chemotherapeutics. Recent publications highlight her work in neutron capture therapy for mesothelioma, applications of boron delivery systems, and novel imaging techniques for Alzheimer's disease and glioma.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

isabella Castellano

Associate Professor

University of Turin

ITALY

Simonetta Geninatti Crich

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

A Comparative Study of 157Gd and 10B Effect in a Carborane-Based Theranostic Agent for Membrane-Targeted Carbonic Anhydrase IX Inhibition and MRI-Guided Neutron Capture Therapy in Mesothelioma Treatment

Cobaltabis(dicarbollide) [o-COSAN]− loaded apoferritin: an innovative high-capacity boron delivery system to target tumour cells for BNCT applications

Capture enhanced neutron irradiation for the treatment of the Alzheimer Disease: Micro-nanodosimetric characterization of beta amyloid peptide samples

Synthesis of fluorinated curcumin derivatives for detecting amyloid plaques by 19F-MRI

Experimental Comparison of Methods to Evaluate Heat Generated by Magnetic Nanofluids Exposed to Alternating Magnetic Fields

Role of Transmembrane Water Exchange in Glioma Invasion/Migration: In Vivo Preclinical Study by Relaxometry at Very Low Magnetic Field

Biotinylation of a MRI/Gd BNCT theranostic agent to access a novel tumour-targeted delivery system

Low-Field NMR Relaxometry for Intraoperative Tumour Margin Assessment in Breast-Conserving Surgery

Monitoring tissue implants by field-cycling H-1-MRI via the detection of changes in the N-14-quadrupolar-peak from imidazole moieties incorporated in a "smart" scaffold material

A novel class of 1H-MRI Contrast Agents based on the relaxation enhancement induced on water protons by 14N imidazole moieties

Cobaltabis(dicarbollide) ([<i>o</i>-COSAN]<sup>&minus;</sup>) as Multifunctional Chemotherapeutics: A Prospective Application in Boron Neutron Capture Therapy (BNCT) for Glioblastoma

LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications

Towards Enhanced MRI Performance of Tumor-Specific Dimeric Phenylboronic Contrast Agents

A Novel Class of 1H‐MRI Contrast Agents Based on the Relaxation Enhancement Induced on Water Protons by 14N‐Containing Imidazole Moieties

Collaborators (15)

isabella Castellano

Filipa Mendes

Michele Forzan

Annamaria Deagostino

David Lurie

Lionel Broche

Ivan Hawala

Roberta Bertani

Lucia Del Bianco

Paolo Sgarbossa

Elisabetta Sieni

Lorenzo TEI

Federico Spizzo

Peter Ross

Polyssena Renzi

Make your next move.

Cobaltabis(dicarbollide) ([<i>o</i>-COSAN]<sup>−</sup>) as Multifunctional Chemotherapeutics: A Prospective Application in Boron Neutron Capture Therapy (BNCT) for Glioblastoma